Arch Therapeutics, Inc. (QB) Stock Price - ARTH

Best deals to access real time data!
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Arch Therapeutics, Inc. (QB) ARTH OTC BB Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.015 -3.85% 0.375 0.39 0.375 0.39 0.39 12:53:48
Bid Price Ask Price Spread Spread % News
0.375 0.385 0.01 2.60% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9 31,830 $ 0.3817 $ 12.15k 190.7k 0.25 - 0.84
Last Trade Time Type Quantity Stock Price Currency
12:59:07 2,002 $0.38 USD

Arch Therapeutics, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 59.93M 159.82M $ -2.95M - -20.33 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Arch Therapeutics, Inc. (QB) News

Date Time Source News Article
10/01/201807:11Edgar (US Regulatory)Current Report Filing (8-k)
9/05/201807:57Edgar (US Regulatory)Current Report Filing (8-k)
8/02/201812:44Edgar (US Regulatory)Quarterly Report (10-q)
7/20/201813:15Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)
7/20/201812:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
7/20/201812:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
7/20/201812:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)

Latest ARTH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARTH Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.36650.4050.3610.380537k323k170k0.00852.32%
1 Month0.410.4450.3610.392337k594k229k-0.035-8.54%
3 Months0.4310.4850.350.408012k696k194k-0.056-12.99%
6 Months0.2860.690.260.428512k2M241k0.08931.12%
1 Year0.7990.8390.250.460412k6M335k-0.424-53.07%
3 Years0.270.9450.16320.516612k9M464k0.10538.89%
5 Years0.2680.9450.00010.45282k9M375k0.10739.93%

Arch Therapeutics, Inc. (QB) Description

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development stage product candidates include the AC5™ Topical Gel and the AC5™ Surgical Hemostatic Device.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20181017 17:57:13